Good evening :)
$
₹
Certara Inc

Certara Inc

CERT

NASDAQ
Asset Logo

Certara Inc

CERT

NASDAQ
$8.600.96% (+0.08)
$
₹
$8.600.96% (+0.08)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Health Information Services

Small Cap

With a market cap of $1.3B the stock is ranked 2560

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.32
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.14
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-16.22%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 11 analysts' reports

Buy
5 analysts
Hold
6 analysts
Sell
0 analyst

Analysts expect a -2.17% price downside over the next year

Current Price$8.60
Target Price$8.33

Company Profile

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Peers

Peers

Veeva Systems Inc Class A
VEEV
Veeva Systems Inc Class A
P/E Ratio
42.72
42.72
1Y Return
7.04%
7.04%
Buy Reco %
59.37
59.37
Waystar Holding Corp. Common Stock
WAY
Waystar Holding Corp. Common Stock
P/E Ratio
36.65
36.65
1Y Return
31.8%
31.8%
Buy Reco %
100.00
100.00
Doximity Inc
DOCS
Doximity Inc
P/E Ratio
31.08
31.08
1Y Return
62.97%
62.97%
Buy Reco %
42.10
42.10
Inspire Medical Systems Inc
INSP
Inspire Medical Systems Inc
P/E Ratio
16.94
16.94
1Y Return
3.57%
3.57%
Buy Reco %
72.22
72.22
Schrodinger Inc
SDGR
Schrodinger Inc
P/E Ratio
—
—
1Y Return
53.34%
53.34%
Buy Reco %
75.00
75.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealth Information Services

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Certara Inc -1.32-
Veeva Systems Inc Class A42.725.661.15
Waystar Holding Corp. Common Stock36.651.23-

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

104.6
1.5
103.6
-5.8
106.9
-8.7
93.2
-55.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue96.6593.3194.82100.36106104.57104.61103.64106.9193.27
Net Income-4.68-12.57-1.376.574.74-1.961.52-5.89-8.76-55.27
Net Profit Margin-4.84%-13.47%-1.44%6.55%4.47%-1.88%1.45%-5.68%-8.19%-59.25%
See CostsAll values in $ Million

Frequently asked questions

  1. Certara Inc (CERT) share price today is $8.60 as of September 22, 2026 at 7:19 PM IST. The stock touched a day high of $8.60 and a day low of $8.52.

  2. Certara Inc stock trades on NASDAQ under the ticker symbol CERT.

  3. Certara Inc's market capitalization is $1.28B as of September 22, 2026 at 7:19 PM IST.

  4. Certara Inc's price-to-earnings (P/E) ratio is N/A as of September 22, 2026.

  5. Certara Inc's price-to-book (P/B) ratio is 1.32 as of September 22, 2026.

  6. Yes, You can buy Certara Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Certara Inc shares in three steps: 1. Search Certara Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Certara Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Certara Inc (CERT) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.1625 shares at the current price of $8.60.

Loading...